At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Description
MS&T Process Analytics & Engineering is seeking a Senior Manager, Devens Process Engineering to support process robustness, process optimization and new technology introductions across the Devens Site and the biologics network. Reporting to the Associate Director of Devens Process Engineering, the Senior Manager will support identification and implementation of productivity improvement opportunities and will support new technology introductions to the Devens site. This role will be responsible for finding new ways to increase production output & efficiency and will support new process and technology introduction into the site.
Key responsibilities would include:
* Identification, design, and proposal of process optimization projects to deliver increased throughput, facility flexibility, process robustness, yield improvement, and improved process capability.
* Facility Fit studies for new process introductions including: equipment sizing and allocation, mass balances, facility dynamic capacity analysis, and schedule analysis.
* Assessing new technology implementation into commercial manufacturing: estimation of project capital costs, timelines, impact to operations, return on investment.
* Driving network harmonization of equipment and automation capabilities for increased supply chain agility & flexibility.
* Develop advanced process models using computational fluid dynamics (CFD) and other modeling tools and approaches.
* Use of Emerson Bio-G scheduling and capacity analysis tool to identify facility bottlenecks, with a view to increasing facility cadence.
* Partnering with site functions (e.g. Manufacturing Technology, Operations, Facilities and Engineering, etc.) to implement and deliver project benefits
* Interface with network SMEs in MS&T, Biologics Development, and site-based colleagues, for process requirements, harmonization of process technology platforms, and technology implementation planning.
Qualifications & Requirements
* The successful candidate must possess an engineering degree in the biotechnology, biochemical, chemical or related disciplines, along with experience in commercial biologics manufacturing PhD (>5yrs), MSc. (>8yrs), BSc. (>10yrs), documented by a solid history of technical accomplishments.
* A strong practical knowledge of the technologies related to cell culture, protein purification, and process engineering is essential, including deep knowledge of equipment, process science, and automation.
* The individual should have the ability to manage and co-ordinate technical projects and be familiar with the manufacturing operations of large scale production facilities as well as GMP experience.
* Experience in design and technology transfer of processes for commercial biologic manufacturing is required.
* The successful candidate will also possess knowledge of process data sources, statistical process control, and engineering analysis tools.
* Experience in modeling and simulation of processes & unit-operations is desired.
* Candidate must be effective in both a team environment and an individual contributor role with minimal supervision.
* Proven ability to work on complex problems in which analysis of situations or data requires an in-depth evaluation of multiple factors is essential.
* Occasional business travel may be required (up to 15%).
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Our company is committed to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace adjustments and ongoing support in their roles. Applicants can request an approval of accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or any part of the recruitment process direct your inquiries to adastaffingsupport@bms.com. Visit careers.bms.com/eeo-accessibility to access our complete Equal Employment Opportunity statement.
Summit, NJ
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE to treat breast, non-small cell lung, pancreatic, and gastric cancers.
The company’s products also include IDHIFA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (rrAML) with an isocitrate dehydrogenase-2 mutation; VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; THALOMID to treat patients with MM; and ISTODAX, an epigenetic modifier. Its preclinical and clinical-stage product candidates include small molecules, biologics, and cell therapies for immune-inflammatory diseases, myeloid diseases, epigenetics, protein homeostasis, and immuno-oncology.
The company has agreements with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; bluebird bio, Inc.; Lycera Corp.; Juno Therapeutics, Inc.; EXSCIENTIA LTD.; and IMIDomics SL, as well as immuno-oncology collaboration with Sutro Biopharma. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.